January 30, 2024

Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition."

January 04, 2024

DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market

December 22, 2023

DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

November 28, 2023

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

November 14, 2023

DSS Inc. Wins Patent Dispute with Nichia Corporation

November 08, 2023

DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock

October 26, 2023

DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule

October 23, 2023

DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical

October 12, 2023

DSS Inc. Issues Letter to Shareholders

September 06, 2023

DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary

July 31, 2023

DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc.

July 05, 2023

DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.

June 30, 2023

DSS Inc. Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.

June 26, 2023

DSS, Inc. Announces Record and Distribution Date for Impact Biomedical Spin-Off Special Dividend

May 16, 2023

DSS, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023

May 01, 2023

DSS Inc. Announces Distribution Date of Sharing Services Shares to DSS Shareholders

April 19, 2023

DSS, Inc. Announces Plan to Distribute Common Stock of Sharing Services Global Corporation to Shareholders

April 17, 2023

DSS, Inc. to Present at Emerging Growth Conference April 19 at 1:45 PM

March 02, 2023

DSS Announces Letter to Shareholders   

October 19, 2022

Impact BioMedical Scientific Partner GRDG Sciences to be Featured in New Documentary

August 30, 2022

DSS Receives New York Stock Exchange Notice Regarding Late Form 10-Q Filing

July 26, 2022

Impact BioMedical Develops Quantum Antihistamine

July 21, 2022

DSS Announces Licensing of Impact BioMedical’s Linebacker Portfolio to ProPhase Labs

July 13, 2022

DSS Strengthens and Expands Board with Appointment of Two Independent Directors

June 28, 2022

Impact BioMedical Announces License Agreement with ProPhase Labs to Produce and Distribute Viral-Fighting Compound Equivir

June 07, 2022

DSS’s Impact BioMedical Receives China Patent for its Functional Fragrance Formulation Mosquito Repellant

May 06, 2022

DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

March 03, 2022

Impact BioMedical’s Proprietary Equivir Compound to Treat Viral Infection Receives Clean Patentability Report from World Intellectual Property Organization’s ISA Division

February 28, 2022

DSS Announces Letter to Shareholders

February 22, 2022

DSS to Present at Aegis Virtual Conference

January 25, 2022

DSS Receives $17 Million Investment from Alset EHome International

January 19, 2022

DSS Acquires 25.1% of Alset International Limited

January 12, 2022

DSS Expands American Medical REIT Subsidiary with Acquisition of 21,900 Sq. Ft. Medical Office Building

January 11, 2022

Impact BioMedical Announces New Bioplastics Test Results

January 10, 2022

DSS Retains Leading Blockchain and Digital Assets Law Firm to Accelerate Launch of Digital Asset Exchange

December 22, 2021

DSS Provides Update on Expansion of Premier Packaging Subsidiary

December 20, 2021

DSS’s American Pacific Bancorp Approaches $20M in New Loans Issued

December 15, 2021

DSS Opens Sacramento Office for its DSS Wealth Management and DSS AmericaFirst Quantitative Funds

December 07, 2021

DSS to Present at the Emerging Growth Conference on December 8

November 30, 2021

DSS Enters Quantitative Investment Fund Arena

November 04, 2021

DSS Expands American Medical REIT with Acquisition of Three Established Acute Care Hospitals in Texas and Pennsylvania

October 28, 2021

DSS, Inc. Interview to Air on Bloomberg U.S. on the RedChip Money Report®

October 20, 2021

DSS Provides Update on its Liquid Value Asset Management Subsidiary

October 05, 2021

DSS, Inc. Issued New CUSIP Number in Conjunction with Previously Announced Name Change

September 20, 2021

Document Security Systems, Inc. to Change Its Name to DSS, Inc. to Reflect Sweeping Organizational Changes and Ongoing Business Expansions

September 09, 2021

DSS Invests $40 Million into American Pacific Bancorp

September 08, 2021

DSS Receives $15 Million Investment from Alset EHome International

September 07, 2021

DSS’s Impact BioMedical Successfully Synthesizes First Quantum-Based Compound

August 23, 2021

DSS’s Impact BioMedical Reports Positive Test Results for its 3FDB “DEET Booster” Technology

August 17, 2021

DSS Promotes Todd D. Macko to CFO